Sort by
Refine Your Search
-
actionable pharmacogene, which could improve prescribing efficacy and safety [1]. Pharmacogenomic-guided (PGx) prescribing may reduce ADE risk by 30% [2]. Aims This PhD project will address knowledge gaps in
-
of stability, safety and echogenicity. The specific objectives are: Investigate a range of lipid formulation / gas combinations to generate a lead formulation with comparable performance characteristics
-
, Security and Justice (contact Brandon Hamber ) For more information about this competition for postgraduate funding with the ESRC-NINE, please visit the Ulster University website , and the ESRC-NINE website
Enter an email to receive alerts for security-"https:"-"https:"-"https:"-"https:"-"IFM" positions